 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE ANNOUNCES NEW CHANNEL FOR EFILM WORKSTATION™
RESELLERS TO SELL VIA ECOMMERCE
eStore Affiliates program provides a new means for small to mid-size organizations to promote and sell eFilm Workstation™, the world’s most widely used
diagnostic workstation
Milwaukee, WI, August 29, 2007 – Merge Healthcare, (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, announced the creation of a new eStore Affiliates program, which enables participating organizations to sell eFilm Workstation and other eCommerce products offered through Merge Healthcare’s industry-leading eCommerce web site.
The eStore Affiliates program represents an expansion of the eCommerce channel, which has provided a cost-effective and user-friendly way to try, buy, license and receive support for eFilm Workstation as well as future eCommerce products.
"Through our Cedara Software division, Merge Healthcare has worked with many partners over the years who currently sell eFilm Workstation, and we expect to continue growing these partnerships," said Beth Frost-Johnson, Senior Vice President of Marketing at Merge Healthcare. "The new eStore Affiliates program gives smaller partners that have lower sales volumes the opportunity to become eFilm resellers. Affiliate partners can directly provide downloads, generate quotes and fulfill orders, and can provide automated electronic communications to prospects and customers for the applications offered through this eCommerce channel."
Partners who agree to the terms of the eStore Affiliate program are eligible to receive commissions for completed orders, have their own customized and branded eStore page for Merge Healthcare’s solutions and will be able to provide customized and automated communications to their customers.
Interested organizations can visit the Merge Healthcare web site at https://www.merge.com/NA/efilmreseller.htm to learn more about the Affiliate program, and about additional partnership opportunities available through Cedara Software.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
Cedara Software is a Merge Healthcare company focused on the development of customized software solutions and development tools for the medical imaging OEM market. Cedara’s solutions enable OEM companies to accelerate their time-to-market, reduce development costs and access new streams of revenue. Cedara’s software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Cedara’s technologies and engineering services span all the major digital imaging modalities and a wide variety of clinical specialties including radiology, orthopaedics, women’s health, oncology, cardiac imaging, clinical trials, imaging for the veterinarian market and more. For additional information, visit our website at www.cedara.com .
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
